Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies (Pending:AKTS)
Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies
Source link
Similar Posts
Puravankara Board of Directors Set to Meet to Discuss Fund-Raising – Equitypandit
Puravankara Limited announced that the board of directors will meet on Tuesday, 6 May, to review a proposal to fund up to Rs 300 crore through private placement issue of secured, redeemable, unlisted, and unrated non-convertible debentures (NCDs). The company wants to issue up to 3,000 NCDs at Rs 10 lakh apiece. The financing will…
Stock Market Reversal – Monster Bounce & What’s Next?
Stock market reversal in the works has been on a rollercoaster, with the QQQ and SPY bouncing hard off major support levels today. After a weak open, stocks staged a monster stock market reversal, catching many traders off guard. But the question remains: Is this a dead cat bounce, or the beginning of a new…
ACWV Vs. ACWI: A Choice Of Long-Term Performance Over Downside Protection (BATS:ACWV)
This article was written by Follow I am a value focused investor. Stocks rise and fall for many different reasons that we often cannot predict. Eventually, it is those companies with a wide moat and the ability to generate cash flow that prevail. Therefore, my investment focus is to find value stocks that are able…
VantagePoint A.I. Stock of the Week Hims and Hers Health ($HIMS) – VantagePoint $HIMS
This week’s ai stock spotlight is HIMS and HERS Health ($HIMS) Hims & Hers Health (NYSE: HIMS) isn’t your run-of-the-mill healthcare stock. It’s a telehealth disruptor that’s flipped the script on how care is delivered and how investors should think about growth in the sector. Founded in 2017 by Andrew Dudum, this company started by…
Take-Two Interactive Software, Inc. 2025 Q1 – Results – Earnings Call Presentation (NASDAQ:TTWO)
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with…
